Literature DB >> 33559010

Magnetic resonance imaging in ankylosing spondylitis: reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar.

Zhi-Xiang Huang1,2, Wei-Ming Deng1,2, Shao-Ling Zheng1,2, Xin Guo1,2, Shao-Qing Zeng2,3, Tian-Wang Li4,5.   

Abstract

Entities:  

Year:  2021        PMID： 33559010     DOI： 10.1007/s10067-021-05628-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis.

Authors:  Walter P Maksymowych; Robert D Inman; David Salonen; Suhkvinder S Dhillon; Martin Williams; Millicent Stone; Barbara Conner-Spady; Janice Palsat; Robert G W Lambert
Journal:  Arthritis Rheum       Date:  2005-10-15

2.  Clinical and MRI response to dose reduction of an etanercept-biosimilar for hip arthritis in patients with ankylosing spondylitis: an observational, retrospective cohort study.

Authors:  Zhi-Xiang Huang; Wei-Ming Deng; Xin Guo; Zheng-Ping Huang; Yu-Kai Huang; Chu-Lan Lin; Tian-Wang Li
Journal:  Clin Rheumatol       Date:  2019-02-12       Impact factor: 2.980

3.  Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.

Authors:  S J Pedersen; U Weber; R Said-Nahal; I J Sørensen; A G Loft; G Kollerup; L Juul; P B Frandsen; G Thamsborg; O R Madsen; J Møller; L Balding; A G Jurik; M Østergaard
Journal:  Scand J Rheumatol       Date:  2018-11-13       Impact factor: 3.641

4.  Application and preliminary validation of the hip inflammation MRI scoring system (HIMRISS) in spondyloarthritis.

Authors:  Yan Zheng; Kui Zhang; Qing Han; Yuewen Hao; Ying Liu; Hong Yin; Jin Ding; Zhaohui Zheng; Nan Leng; Junfeng Jia; Zhenbiao Wu; Ping Zhu
Journal:  Int J Rheum Dis       Date:  2018-12-11       Impact factor: 2.454

5.  Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score.

Authors:  Walter P Maksymowych; Stephanie Wichuk; Praveena Chiowchanwisawakit; Robert G Lambert; Susanne J Pedersen
Journal:  J Rheumatol       Date:  2014-10-15       Impact factor: 4.666

6.  The application of MR imaging in the detection of hip involvement in patients with ankylosing spondylitis.

Authors:  Zhen-Guo Huang; Xue-Zhe Zhang; Wen Hong; Guo-Chun Wang; Hui-Qiong Zhou; Xin Lu; Wu Wang
Journal:  Eur J Radiol       Date:  2013-05-13       Impact factor: 3.528

7.  Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Robert G W Lambert; David Salonen; Proton Rahman; Robert D Inman; Robert L Wong; Steven G Einstein; Glen T D Thomson; Andre Beaulieu; Denis Choquette; Walter P Maksymowych
Journal:  Arthritis Rheum       Date:  2007-12

Review 8.  Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis.

Authors:  Sizheng Zhao; Laura Chadwick; Eduardo Mysler; Robert J Moots
Journal:  Curr Rheumatol Rep       Date:  2018-08-09       Impact factor: 4.592

9.  Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.

Authors:  Jinmei Su; Mengtao Li; Lan He; Dongbao Zhao; Weiguo Wan; Yi Liu; Jianhua Xu; Jian Xu; Huaxiang Liu; Lindi Jiang; Huaxiang Wu; Xiaoxia Zuo; Cibo Huang; Xiumei Liu; Fen Li; Zhiyi Zhang; Xiangyuan Liu; Lingli Dong; Tianwang Li; Haiying Chen; Jingyang Li; Dongyi He; Xin Lu; Anbin Huang; Yi Tao; Yanyan Wang; Zhuoli Zhang; Wei Wei; Xiaofeng Li; Xiaofeng Zeng
Journal:  BioDrugs       Date:  2020-06       Impact factor: 5.807
  9 in total
  1 in total

1.  Measurement of pre-treatment inflammatory cytokine levels is valuable for prediction of treatment efficacy to tumor necrosis factor inhibitor in axial spondyloarthritis patients.

Authors:  Fei Peng; Fengyun Chen; Huijun Wen; Jie Bai; Yuping Tian
Journal:  Int J Rheum Dis       Date:  2022-06-12       Impact factor: 2.558
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.